1.0
Oct 15, 2019
Current employee
Recommend
CEO approval
Business Outlook
Pros
High base salary, autonomy IF you have a good manager
Cons
Current drug has a very limited indication, stock has steadily declined since the drugs approval, limited pipeline. Upper level management and the CEO make claims with no proof (I.e. Chance of first line indication, being added to guidelines) Very few teams are making goal but management keeps raising the goals, the sales team seems deflated and management doesn't seem to care